Aker Christopher Ray — insider trades

Stock trades Aker Christopher Ray reported on SEC Form 4 at RGLS Regulus Therapeutics Inc..

• Jan 14, 2025: sold 43,635 shares of RGLS Regulus Therapeutics Inc. ($55.0K)